University of Michigan-Ann Arbor · NeuroscienceCallaghan Lab
Brian Christopher Callaghan · Ann Arbor, Michigan
Research Focus
Dr. Brian Callaghan's lab focuses on understanding the effectiveness and cost-effectiveness of new treatments for Alzheimer's disease, especially in Black and low-income populations. By evaluating the real-world impacts of anti-amyloid medications, the lab aims to address healthcare disparities and improve access to effective treatments. This research is crucial for ensuring that vulnerable populations receive equitable healthcare benefits while navigating potential challenges like adverse events and cost barriers.
Alzheimer's Diseasecost-effectivenessanti-amyloid medicationshealthcare disparitiesvulnerable populations
Research Aims
3AIM 01Engage stakeholders to understand real-world preferences impacting Alzheimer's treatment effectiveness.
AIM 02Analyze healthcare claims data to determine utilization costs and adverse event rates of anti-amyloid medications.
AIM 03Estimate the effectiveness and cost-effectiveness of anti-amyloid treatments in Black low-income populations.
Skills the Lab Values
qualitative interviewsquantitative surveyshealthcare claims analysisMonte Carlo simulationdata analysis
Output against the department
Publications300top 22% of dept.150th of 671
this lab
most publishedleast published
Citations13ktop 31% of dept.208th of 671
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.